AlongiF., ArcangeliS., FilippiA.R., RicardiU., ScorsettiM.: Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist, 17: 1100–1107, 2012.
3.
IyengarP., WestoverK., TimmermanR.D.: Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer. Semin Respir Crit Care Med, 34: 845–854, 2013.
FuksZ., KolesnickR.: Engaging the vascular component of the tumor response. Cancer Cell, 8: 89–91, 2005.
6.
BekelmanJ.E., EpsteinA.J., EmanuelE.J.: Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer. JAMA, 310: 1501–1502, 2013.
7.
GrecoC., ZelefskyM.J., LovelockM., FuksZ., HuntM., RosenzweigK., ZatckyJ., KimB., YamadaY.: Predictors of local control after single-dose stereotactic image-guided intensitymodulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys, 79: 1151–1157, 2011.
8.
ZelefskyM.J., GrecoC., MotzerR., MagsanocJ.M., PeiX., LovelockM., MechalakosJ., ZatckyJ., FuksZ., YamadaY.: Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys, 82: 1744–1748, 2012.
